Skip to main content
. 2023 Jul 3;36(5):477–489. doi: 10.20524/aog.2023.0815

Table 3.

Special precautions when using RBN in LT patients receiving CNI or mTOR inhibitor

graphic file with name AnnGastroenterol-36-477-g005.jpg